Erythroid differentiation regulator 1, an interleukin 18-regulated gene, acts as a metastasis suppressor in melanoma

Journal of Investigative Dermatology

Volumn 131, Issue 10, 2011, Pages 2096-2104

  Jung, Min Kyung ^a   Park, Yoorim ^a   Song, Seok Bean ^a   Cheon, So Young ^a   Park, Sunyoung ^a   Houh, Younkyung ^b   Ha, Soogyeong ^a   Kim, Hee Jung ^c   Park, Jung Min ^d   Kim, Tae Sung ^e   Lee, Wang Jae ^f   Cho, Byung Joo ^g   Bang, Sa Ik ^h   Park, Hyunjeong ^c   Cho, Daeho ^a  

^a Sookmyung Women's University   (South Korea)

^b Konkuk University   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d Cent'l Res Inst   (South Korea)

^e Korea University   (South Korea)

^f Seoul National University College of Medicine   (South Korea)

^g Konkuk University Hospital   (South Korea)

^h Sungkyunkwan University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROID DIFFERENTIATION REGULATOR 1 PROTEIN; HEAT SHOCK PROTEIN 90; INTERLEUKIN 18; REGULATOR PROTEIN; SMALL INTERFERING RNA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; MELANOMA; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 80052851312     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.170     Document Type: Article

References (47)

1. Antoni MH, Lutgendorf SK, Cole SW et al. (2006) The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer 6:240-8 (Pubitemid 43292567)
2. Becker B, Multhoff G, Farkas B et al. (2004) Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases. Exp Dermatol 13:27-32 (Pubitemid 38165435)
3. Bouzahzah B, Albanese C, Ahmed F et al. (2001) Rho family GTPases regulate mammary epithelium cell growth and metastasis through distinguishable pathways. Mol Med 7:816-30 (Pubitemid 34175305)
4. Boyd D (1996) Invasion and metastasis. Cancer Metastasis Rev 15:77-89 (Pubitemid 26248352)
5. Carrascal MT, Mendoza L, Valcarcel M et al. (2003) Interleukin-18 binding protein reduces b16 melanoma hepatic metastasis by neutralizing adhesiveness and growth factors of sinusoidal endothelium. Cancer Res 63:491-7 (Pubitemid 36152512)
6. Chandrasekar B, Mummidi S, Mahimainathan L et al. (2006) Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-kappaB-and AP-1-mediated matrix metalloprotei-nase-9 expression and is inhibited by atorvastatin. J Biol Chem 281: 15099-109 (Pubitemid 43855099)
7. Chin L (2003) The genetics of malignant melanoma: lessons from mouse and man. Nat Rev Cancer 3:559-70 (Pubitemid 37328828)
8. Cho D, Song H, Kim YM et al. (2000) Endogenous interleukin-18 modulates immune escape of murine melanoma cells by regulating the expression of Fas ligand and reactive oxygen intermediates. Cancer Res 60: 2703-9 (Pubitemid 30318247)
9. Dai C, Whitesell L (2005) HSP90: a rising star on the horizon of anticancer targets. Future Oncol 1:529-40
10. Dormer P, Spitzer E, Frankenberger M et al. (2004a) Erythroid differentiation regulator (EDR), a novel, highly conserved factor I. Induction of haemoglobin synthesis in erythroleukaemic cells. Cytokine 26: 231-42 (Pubitemid 38739427)
11. Dormer P, Spitzer E, Moller W (2004b) EDR is a stress-related survival factor from stroma and other tissues acting on early haematopoietic progenitors (E-Mix). Cytokine 27:47-57 (Pubitemid 38881526)
12. Eccles SA, Massey A, Raynaud FI et al. (2008) NVP-AUY922: a novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasis. Cancer Res 68:2850-60 (Pubitemid 351556284)
13. Fanelli MA, Montt-Guevara M, Diblasi AM et al. (2008) P-cadherin and beta-catenin are useful prognostic markers in breast cancer patients; beta-catenin interacts with heat shock protein Hsp27. Cell Stress Chaperones 13:207-20
14. Ferrone S, Marincola FM (1995) Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol Today 16:487-94
15. Gaggero A, De Ambrosis A, Mezzanzanica D et al. (2004) A novel isoform of pro-interleukin-18 expressed in ovarian tumors is resistant to caspase-1 and-4 processing. Oncogene 23:7552-60 (Pubitemid 39389697)
16. Golab J (2000) Interleukin 18-interferon gamma inducing factor-a novel player in tumour immunotherapy? Cytokine 12:332-8 (Pubitemid 30449823)
17. Haass NK, Smalley KS, Li L et al. (2005) Adhesion, migration and communication in melanocytes and melanoma. Pigment Cell Res 18:150-9 (Pubitemid 40733333)
18. Huber D, Philipp J, Fontana A (1992) Protease inhibitors interfere with the transforming growth factor-beta-dependent but not the transforming growth factor-beta-independent pathway of tumor cell-mediated immunosuppression. J Immunol 148:277-84
19. Hyoudou K, Nishikawa M, Kobayashi Y et al. (2008) SOD derivatives prevent metastatic tumor growth aggravated by tumor removal. Clin Exp Metastasis 25:531-6
20. Jeanes A, Gottardi CJ, Yap AS (2008) Cadherins and cancer: how does cadherin dysfunction promote tumor progression? Oncogene 27:6920-9
21. Jung MK, Song HK, Kim KE et al. (2006) IL-18 enhances the migration ability of murine melanoma cells through the generation of ROI and the MAPK pathway. Immunol Lett 107:125-30 (Pubitemid 44779815)
22. Kampfer H, Muhl H, Manderscheid M et al. (2000) Regulation of inter-leukin-18 (IL-18) expression in keratinocytes (HaCaT): implications for early wound healing. Eur Cytokine Netw 11:626-33 (Pubitemid 32044247)
23. Lees JG, Bach CT, O'Neill GM (2011) Interior decoration: tropomyosin in actin dynamics and cell migration. Cell Adh Migr 5:181-6
24. Liu DH, Yuan HY, Cao CY et al. (2007) Heat shock protein 90 acts as a molecular chaperone in late-phase activation of extracellular signal-regulated kinase 1/2 stimulated by oxidative stress in vascular smooth muscle cells. Acta Pharmacol Sin 28:1907-13
25. Majima T, Ichikura T, Chochi K et al. (2006) Exploitation of interleukin-18 by gastric cancers for their growth and evasion of host immunity. Int J Cancer 118:388-95 (Pubitemid 41779078)
26. Mancianti ML, Herlyn M (1989) Tumor progression in melanoma: the biology of epidermal melanocytes in vitro. Carcinog Compr Surv 11:369-86
27. McCarthy MM, Pick E, Kluger Y et al. (2008) HSP90 as a marker of progression in melanoma. Ann Oncol 19:590-4 (Pubitemid 351325684)
28. McCord JM (2002) Superoxide dismutase in aging and disease: an overview. Methods Enzymol 349:331-41 (Pubitemid 34229520)
29. Miyata Y, Kanda S, Ohba K et al. (2006) Lymphangiogenesis and angio-genesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A,-C, and-D. Clin Cancer Res 12: 800-6 (Pubitemid 43259860)
30. Mukherji B, Chakraborty NG (1995) Immunobiology and immunotherapy of melanoma. Curr Opin Oncol 7:175-84
31. Okamura H, Tsutsi H, Komatsu T et al. (1995) Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378:88-91
32. Park S, Cheon S, Cho D (2007) The dual effects of interleukin-18 in tumor progression. Cell Mol Immunol 4:329-35
33. Quarta S, Vidalino L, Turato C et al. (2010) SERPINB3 induces epithelial-mesenchymal transition. J Pathol 221:343-56
34. Sarto C, Binz PA, Mocarelli P (2000) Heat shock proteins in human cancer. Electrophoresis 21:1218-26 (Pubitemid 30230786)
35. Satyamoorthy K, Herlyn M (2002) Cellular and molecular biology of human melanoma. Cancer Biol Ther 1:14-7
36. Soo ET, Yip GW, Lwin ZM et al. (2008) Heat shock proteins as novel therapeutic targets in cancer. In Vivo 22:311-5
37. Stellas D, El Hamidieh A, Patsavoudi E (2010) Monoclonal antibody 4C5 prevents activation of MMP2 and MMP9 by disrupting their interaction with extracellular HSP90 and inhibits formation of metastatic breast cancer cell deposits. BMC Cell Biol 11:51
38. Stoll S, Muller G, Kurimoto M et al. (1997) Production of IL-18 (IFN-gamma-inducing factor) messenger RNA and functional protein by murine keratinocytes. J Immunol 159:298-302 (Pubitemid 127493712)
39. Sugama S, Kim Y, Baker H et al. (2000) Tissue-specific expression of rat IL-18 gene and response to adrenocorticotropic hormone treatment. J Immunol 165:6287-92
40. Temoshok L (1985) Biopsychosocial studies on cutaneous malignant melanoma: psychosocial factors associated with prognostic indicators, progression, psychophysiology and tumor-host response. Soc Sci Med 20:833-40 (Pubitemid 15229044)
41. Tong Z, Kunnumakkara AB, Wang H et al. (2008) Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer. Cancer Res 68:6100-8
42. Tsutsumi S, Scroggins B, Koga F et al. (2008) A small molecule cell-impermeant Hsp90 antagonist inhibits tumor cell motility and invasion. Oncogene 27:2478-87 (Pubitemid 351521101)
43. Versteeg HH, Spek CA, Peppelenbosch MP et al. (2004) Tissue factor and cancer metastasis: the role of intracellular and extracellular signaling pathways. Mol Med 10:6-11 (Pubitemid 39440315)
44. Vuoriluoto K, Haugen H, Kiviluoto S et al. (2011) Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer. Oncogene 30:1436-48
45. Whitesell L, Lindquist SL (2005) HSP90 and the chaperoning of cancer. Nat Rev Cancer 5:761-72 (Pubitemid 41400776)
46. Zhang T, Kawakami K, Qureshi MH et al. (1997) Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoformans through production of gamma interferon by natural killer cells. Infect Immun 65:3594-9 (Pubitemid 27398112)
47. Zhang Y, Wang JS, Chen LL et al. (2004) Repression of hsp90beta gene by p53 in UV irradiation-induced apoptosis of Jurkat cells. J Biol Chem 279: 42545-51 (Pubitemid 39372138)